O=C1[C@H]2[C@@H](C(=O)N1C1CCCCC1)[C@@H](c1ccc(F)cc1)N1C(=O)N(c3cccc(Cl)c3)C(=O)[C@@]21Cc1ccc(Cl)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?